Sath Shukla, CEO and President at Spero Therapeutics, Inc. (SPRO), sold 32,441 shares at $1.32 ($43K) on 2024-08-02, disclosed to the SEC on 2024-08-06.
Seasonal sale ($43k) by CEO and President — this insider has traded SPRO in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.32 | 14,800 | $20K | 45.8% |
| 2 | $1.31 | 17,641 | $23K | 54.2% |
| Total | $1.31 avg | 32,441 | $43K | 100% |
| Filing → |
| SPRO | SELL | 2024-02-05 | $173K | — | Filing → |
| SPRO | SELL | 2023-08-30 | $8K | — | Filing → |
| SPRO | SELL | 2023-02-03 | $17K | — | Filing → |